Orthopediatrics Corp

  • Earnings Score
  • Moat Score
  • Safety Score
  • Market Cap $497.68M
  • PE -13
  • Debt $78.38M
  • Cash $45.78M
  • EV $530.29M
  • FCF -$41.31M

Earnings

loading chart...

Sales & Net Margins

loading chart...
Earnings-$37.82M
EBIT-$35.01M
ROE-11%
ROA-7%
FCF-$41.31M
Equity$354.57M
Growth Stability1
PE-13.16
PEG18.58
PB1.4
P/FCF-12.05
P/S2.43
Price/Cash0.09
Debt/Equity0.22
Debt/FCF-1.9
Net Margins-18%
Gross Margins73%
Op. Margins-17%
Earnings CAGR-0%
Sales Growth YoY40%
Sales Growth QoQ-3%
Sales CAGR22%
Equity CAGR37%
Earnings Stability-0.04
Earnings Growth YoY140%
Earnings Growth QoQ103%
Earnings CAGR 5Y-1%
Sales CAGR 5Y26%
Equity CAGR 5Y19%
Earnings CAGR 3Y28%
Sales CAGR 3Y28%
Equity CAGR 3Y14%
Market Cap$497.68M
Revenue$204.73M
Assets$473.21M
Total Debt$78.38M
Cash$45.78M
Shares Outstanding23.06M
EV530.29M
Earnings Score6%
Moat Score4%
Safety Score66%
Final Score26%
Working Capital203.21M
Current Ratio6.98
Gross Profit$148.60M
Shares Growth 3y7%
Equity Growth QoQ-4%
Equity Growth YoY-6%

Assets & ROA

loading chart...

Stockholders Equity & ROE

loading chart...
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercialize implants and instruments to meet the needs of surgeons and patients. Its products, include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia and ACL Reconstruction System among others.

SEC Filings

Direct access to Orthopediatrics Corp (KIDS) Annual Reports (10K) and Quarterly Reports (10Q) from the SEC website.

  • 2024
    • 10-K Dec 31
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31
  • 2023
    • 10-K Dec 31
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31
  • 2022
    • 10-K Dec 31
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31

Sector Comparison

How does Orthopediatrics Corp compare to its competitors?

Loading chart...

Peter Lynch's Chart

This chart shows the current pricing of Orthopediatrics Corp compared to its past. The addition of the earnings trend line provides further insights into the company's earnings power.

CAGR -0%
Stability -4%
loading chart...

Orthopediatrics Corp Discounted Cash Flow

Fully customizable DCF calculator online for Orthopediatrics Corp.

= -$413M
012345678910TV
fcf-$41M-$41M-$41M-$41M-$41M-$41M-$41M-$41M-$41M-$41M-$41M-$413M
DCF-$38M-$34M-$31M-$28M-$26M-$23M-$21M-$19M-$18M-$16M-$159M
Value-$413M

Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years12/201512/201612/201712/201812/201912/202012/202112/202212/202312/2024TTM
Net Margins-41%-33%-52%-21%-19%-46%-17%1%-14%-18%-18%
ROA--20%-8%-9%-5%-8%-6%-1%-5%-7%-7%
ROE-19%-50%-15%-10%-14%-7%0%-6%-11%-11%

Safety and Stability

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years12/201512/201612/201712/201812/201912/202012/202112/202212/202312/2024TTM
Debt over FCF--3.23-2.06-1.03-0.89-0.04-0.06-0.03-0.26-1.9-1.9
Debt over Equity--0.270.540.260.180.010.0100.030.220.22
Growth Stability----------1

Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years12/201512/201612/201712/201812/201912/202012/202112/202212/202312/2024CAGR 5Y
Revenue YoY growth-20%22%26%26%-2%38%25%22%38%26%
Earnings YoY growth--2%89%-49%14%140%-51%-108%-2K%80%-1%
Equity YoY growth-21%-173%72%74%65%-4%68%-0%-6%19%
FCF YoY growth-76%127%68%41%-1%-27%50%38%-6%-